Israeli Ministry of Health grants regulatory approval to Imagindairy for precision-fermented milk proteins
Related posts
Biotech firm Pluri has announced a strategic proof of concept (POC) agreement with what it refers to as a “leading international agriculture corporation”.
The agreement is intended to boost global vegetable product supply, streamline supply chains and combat global climate change while ensuring a natural and more sustainable future for agriculture.
The collaboration is set to leverage the strengths of both companies – Pluri's expertise in cell-expansion technologies and cell-ag will complement the partner’s global presence, knowledge of the food industry and position in the vegetable market.
Pluri’s proprietary 3D cell expansion technology is expected to benefit farmers worldwide, as the collaboration can build a better agronomic and environmentally friendly infrastructure, bringing sustainable, high-quality solutions to the market. The collaboration will have the potential to minimise environmental impact of vegetable production, fostering greater food security.
Yaky Yanay, CEO and president of Pluri, said: “As the global population expands, resource competition and climate change heighten the urgency to develop alternative agricultural technologies to replace traditional methods. This new collaboration showcases Pluri's strategy to work with leading global companies from various industries, each an expert in their respective field.”
He continued: “It also aligns with our ongoing commitment to generate revenue through innovative projects. We are confident that this collaboration has the potential not only to positively impact the vegetable market, but also to generate significant value for our shareholders."
It has been a busy year so far for Pluri – in March, Pluri received new patent approval for its 3D bioreactor technology for use in plant cell cultivation. May saw the firm partner with Wilk to develop medical food for the elderly, combining Pluri’s 3D cell expansion tech with Wilk’s expertise in developing cultured human breast milk and animal milk products. And, last month, Pluri's subsidiary, Ever After Foods, secured $10 million from strategic investors.
#Pluri #Israel #plantcellcultivation
Phoebe Fraser
9 July 2024